KCLU 88.3FM - 102.3FM - 1340AM

Listen Now On Point 9:00am - 11:00am

Amgen Settlement With Government Over Marketing Of Drug Finalized

Posted on Wednesday, December 19, 2012 4:59pm


A New York judge today accepted a guilty plea by a biotech giant based in Ventura County over charges it illegally introduced a misbranded drug into interstate commerce, and will pay a total of $150 million dollars in penalties and fines.

The issue was Amgen’s marketing of the anemia drug Aranesp.

The Thousand Oaks company will also pay more than $600 million dollars to settle civil litigation involved with Aranesp, and some other drugs. The total payout by Amgen is $762 million dollars.

The company also admitted it made mistakes, and has realigned its compliance efforts to insure something similar doesn’t happen in the future.


KCLU Local News

KCLU Featured Stories